1. Home
  2. ABEO vs JMSB Comparison

ABEO vs JMSB Comparison

Compare ABEO & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • JMSB
  • Stock Information
  • Founded
  • ABEO N/A
  • JMSB 2005
  • Country
  • ABEO United States
  • JMSB United States
  • Employees
  • ABEO N/A
  • JMSB N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • ABEO Health Care
  • JMSB Finance
  • Exchange
  • ABEO Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • ABEO 237.4M
  • JMSB 268.9M
  • IPO Year
  • ABEO 1980
  • JMSB N/A
  • Fundamental
  • Price
  • ABEO $4.68
  • JMSB $16.63
  • Analyst Decision
  • ABEO Strong Buy
  • JMSB
  • Analyst Count
  • ABEO 5
  • JMSB 0
  • Target Price
  • ABEO $17.00
  • JMSB N/A
  • AVG Volume (30 Days)
  • ABEO 503.6K
  • JMSB 18.0K
  • Earning Date
  • ABEO 03-20-2025
  • JMSB 04-24-2025
  • Dividend Yield
  • ABEO N/A
  • JMSB 1.50%
  • EPS Growth
  • ABEO N/A
  • JMSB 233.33
  • EPS
  • ABEO N/A
  • JMSB 1.20
  • Revenue
  • ABEO N/A
  • JMSB $53,688,000.00
  • Revenue This Year
  • ABEO N/A
  • JMSB N/A
  • Revenue Next Year
  • ABEO $561.86
  • JMSB N/A
  • P/E Ratio
  • ABEO N/A
  • JMSB $13.83
  • Revenue Growth
  • ABEO N/A
  • JMSB 38.38
  • 52 Week Low
  • ABEO $3.05
  • JMSB $15.00
  • 52 Week High
  • ABEO $8.45
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 36.32
  • JMSB 36.69
  • Support Level
  • ABEO $4.42
  • JMSB $16.86
  • Resistance Level
  • ABEO $5.14
  • JMSB $17.50
  • Average True Range (ATR)
  • ABEO 0.25
  • JMSB 0.46
  • MACD
  • ABEO -0.05
  • JMSB 0.01
  • Stochastic Oscillator
  • ABEO 25.24
  • JMSB 10.20

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: